A Study to Evaluate the Effect of Verapamil on the Pharmacokinetics of ASP015K in Healthy Adult Subjects
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of verapamil, a P-glycoprotein (P-gp)
inhibitor, on the pharmacokinetics of ASP015K. This study will also assess the safety and
tolerability of ASP015K administered alone and also and in combination with verapamil.